Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyling Cheok

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Nature Medicine|May 26, 2022
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemiaAndy G X Zeng, Suraj Bansal, Liqing Jin, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Cell Reports|January 23, 2020
Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone MarrowEtienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Blood Advances|March 9, 2021
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesisFlorian Renosi, Anne Roggy, Ambre Giguelay, et al.
Leukemia Research|February 8, 2017
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AMLAminetou Mint Mohamed, Marie Balsat, Catherine Koering, et al.
Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.
Haematologica|October 15, 2020
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeLoria Zalmaï, Pierre-Julien Viailly, Sabeha Biichle, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Nature Medicine|May 26, 2022
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemiaAndy G X Zeng, Suraj Bansal, Liqing Jin, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Cell Reports|January 23, 2020
Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone MarrowEtienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Blood Advances|March 9, 2021
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesisFlorian Renosi, Anne Roggy, Ambre Giguelay, et al.
Leukemia Research|February 8, 2017
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AMLAminetou Mint Mohamed, Marie Balsat, Catherine Koering, et al.
Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.
Haematologica|October 15, 2020
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeLoria Zalmaï, Pierre-Julien Viailly, Sabeha Biichle, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Pageof 5